Literature DB >> 21156098

Assessment of varicella vaccine effectiveness in Germany: a time-series approach.

M Höhle1, A Siedler, H-M Bader, M Ludwig, U Heininger, R Von Kries.   

Abstract

A multivariate time-series regression model was developed in order to describe the 2005-2008 age-specific time-course of varicella sentinel surveillance data following the introduction of a varicella childhood vaccination programme in Germany. This ecological approach allows the assessment of vaccine effectiveness under field conditions by relating vaccine coverage in cohorts of 24-month-old children to the mean number of cases per reporting unit in the sentinel network. For the 1-2 years age group, which is directly affected by the vaccination programme, a one-dose vaccine effectiveness of 83·2% (95% CI 80·2-85·7) was estimated which corresponds to previous approaches assessing varicella vaccine effectiveness in the field in the USA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21156098     DOI: 10.1017/S0950268810002815

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

Review 1.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

2.  Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012.

Authors:  Silvio Tafuri; Francesca Fortunato; Maria Giovanna Cappelli; Vanessa Cozza; Angela Bechini; Paolo Bonanni; Domenico Martinelli; Rosa Prato
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 3.  The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.

Authors:  Pier Luigi Lopalco; Frank DeStefano
Journal:  Vaccine       Date:  2014-11-04       Impact factor: 3.641

Review 4.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

Review 5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

6.  Bayesian penalized spline models for the analysis of spatio-temporal count data.

Authors:  Cici Bauer; Jon Wakefield; Håvard Rue; Steve Self; Zijian Feng; Yu Wang
Journal:  Stat Med       Date:  2015-11-03       Impact factor: 2.373

7.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

8.  Disease burden of herpes zoster in Sweden--predominance in the elderly and in women - a register based study.

Authors:  Marie Studahl; Max Petzold; Tobias Cassel
Journal:  BMC Infect Dis       Date:  2013-12-12       Impact factor: 3.090

9.  Assessing the vaccine effectiveness for hand, foot, and mouth disease in Guangzhou, China: a time-series analysis.

Authors:  Zhicheng Du; Yong Huang; Michael S Bloom; Zhoubin Zhang; Zhicong Yang; Jianyun Lu; Jianxiong Xu; Yuantao Hao
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

10.  Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011.

Authors:  Andrea Streng; Veit Grote; David Carr; Christine Hagemann; Johannes G Liese
Journal:  BMC Infect Dis       Date:  2013-07-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.